Cue Biopharma Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.24

-0.01 (-4.58%)

As of Mar 29, 10:53 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +6,478.9% upside

Low Target $10.91

Average Target $15.75

High Target $18.65

Current Price $0.24

Current
$0.24

Target
$15.75

$10.91 $15.75 avg $18.65

Scenario Analysis

Bear Case

$10.91

4,457.2%

Low target

Base Case

$15.75

+6,478.9%

Avg target

Bull Case

$18.65

+7,690.3%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$1.05

-77.2% from high

52-Week Low

$0.23

+4.0% from low

Target vs 52W High

$15.75

+1,400.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.9%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+157.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.5%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.0%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.5%